Galderma Group AG
F:PY30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galderma Group AG
F:PY30
|
CH |
|
Aya Gold & Silver Inc
NASDAQ:AYA
|
CA |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
|
C
|
Coloplast A/S
F:CBH
|
DK |
Wall St Price Targets
PY30 Price Targets Summary
Galderma Group AG
According to Wall Street analysts, the average 1-year price target for PY30 is 38.75 EUR with a low forecast of 30.81 EUR and a high forecast of 55.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PY30's stock price target?
Price Target
38.75
EUR
According to Wall Street analysts, the average 1-year price target for PY30 is 38.75 EUR with a low forecast of 30.81 EUR and a high forecast of 55.25 EUR.
What is the Revenue forecast for Galderma Group AG?
Projected CAGR
18%
Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for Galderma Group AG?
Projected CAGR
19%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
37%
Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is 37%.
What is the Pre-Tax Income forecast for Galderma Group AG?
Projected CAGR
55%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 55%.
What is the Net Income forecast for Galderma Group AG?
Projected CAGR
47%
The compound annual growth rate for Net Income over the next 3 years is 47%.
